Recent Medical releases

Zaluvida Announces New Scientific Advisory Board

[PRESSWIRE] Boston, MA - June 12, 2018 -- Zaluvida a global life science group, announced today the formation of a Scientific Advisory Board (SAB) to inform the Human Health Research & Development department about the latest research, scientific methods, and opportunities for weight-loss management, and help further technology and product development for the company.

Media alert: Fourth Congress of the European Academy of Neurology, 16 – 19 June 2018, Lisbon, Portugal

[PRESSWIRE] Lisbon, Portugal - 12 June, 2018 -- The Fourth Congress of the European Academy of Neurology (EAN) will take place at the Lisboa Congress Centre in Lisbon from 16 to 19 June. This major scientific event will attract thousands of participants from European and non-European countries.

O IV Congress of the European Academy of Neurology, (Congresso da Academia Europeia de Neurologia) ocorrerá em Lisboa, Portugal, de 16 a 19 de junho de 2018

[PRESSWIRE] Lisbon, Portugal - 12 June, 2018 -- O IV Congress of the European Academy of Neurology (EAN) terá lugar no Centro de Congressos de Lisboa, em Lisboa, de 16 a 19 de junho. Este importante evento científico atrairá milhares de participantes de países europeus e não europeus.

Cancer Support Community Releases Research at ASCO

 [PRESSWIRE] WASHINGTON, May 31, 2018 /PRNewswire-USNewswire/ -- As part of the upcoming American Society of Clinical Oncology's (ASCO) annual conference in Chicago, June 1st through the 4th, the Cancer Support Community (CSC), a global nonprofit, will release three new research studies.

A pre-emptive kidney transplant is still the best option for patients with kidney failure

[PRESSWIRE] Copenhagen, Denmark - 25 May, 2018  -- A new analysis [1], published in Nephrology Dialysis Transplantation during this week’s ERA-EDTA Congress in Copenhagen, confirms that a kidney transplant before start of dialysis extends the life of both the patient and the transplanted organ. However, for patients who do not receive a preemptive transplant, the length of time they spend dialysis (dialysis vintage) no longer appears to reduce their life expectancy after transplantation.

Addressing cardiovascular risk factors can help to improve access to, and outcomes of, kidney transplantation

[PRESSWIRE] Copenhagen, Denmark - 25 May, 2018  -- A review [1] published in Nephrology Dialysis Transplantation (NDT) during the ERA-EDTA Congress in Copenhagen highlights the importance of controlling all metabolic risk factors for cardiovascular disease in every potential kidney transplant candidate, both before and after transplantation.

Can ferric citrate improve the outcome of predialysis patients?

[PRESSWIRE] Copenhagen, Denmark - 25 May, 2018  -- A late breaking clinical study [1] at the ERA-EDTA Congress in Copenhagen showed that the phosphate binder ferric citrate improves multiple aspects of abnormal mineral metabolism and raises hemoglobin in patients with advanced chronic kidney disease (CKD), who do not have abnormal levels of blood phosphate or anemia. 

ERA-EDTA is the first medical association that invests in ‘greener’ healthcare!

[PRESSWIRE] Copenhagen, Denmark - 25 May, 2018  -- The ERA-EDTA is the leading society in Europe for physicians working in the field of care for patients with kidney disease – and is the first medical association to try and implement ‘greener’ health care as suggested by the ‘Lancet Countdown’. Technical progress, e-health, the support of home and self care schemes and sustainable healthcare education and research are ways to ‘greener’ nephrology.

Abatacept for lupus nephritis: no improvement in one year remission rate but faster falls in proteinuria and effects on serologic markers

[PRESSWIRE] Copenhagen, Denmark - 25 May, 2018  -- Over a third of systemic lupus erythematosus (SLE) patients have kidney involvement (lupus nephritis), and are at risk of end-stage renal disease and premature death. Current therapies are toxic and not routinely effective, so novel therapy options are urgently needed. 

Shedding a new light: The implication of microRNAs in chronic kidney disease

[PRESSWIRE] Copenhagen, Denmark - 25 May, 2018  -- Development of disease is often related to the deregulation of a gene program controlled at the post-transcriptional level by microRNAs (miRNAs). A new review [1], published in Nephrology Dialysis Transplantation during this week’s ERAEDTA Congress in Copenhagen, shows that miRNAs are potential innovative biomarkers, and are promising as groundbreaking drugs. “The review of Laurent Metzinger and colleagues summarizes the current state of art of the research on miRNAs in kidney disease”, explains Professor Denis Fouque, editor-in-chief of Nephrology, Dialysis, Transplantation (NDT).